|Podcasts|May 14, 2021

Addressing parental concerns about the COVID-19 vaccine

Contemporary Pediatrics sat down with Dr. Donna Hallas to discuss how to communicate with parents as well as how to address vaccines missed because of the pandemic.

The COVID-19 vaccine offers some challenges for addressing the vaccine hesitant parent. We sat down with Dr. Donna Hallas to discuss how to communicate with parents as well as how to address vaccines missed because of the pandemic.

Newsletter

Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.

Subscribe

Related Content

FDA approves first generic rifapentine for tuberculosis treatment, prevention in 12 years and older

Latest CME

Video

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Nihar R. Desai, MD, MPH; Martha Gulati, MD, MS, FACC, FAHA, MASPC, FESC, FSCCT (hon), FRCP Edin

Addressing parental concerns about the COVID-19 vaccine

Related Content

FDA approves first generic rifapentine for tuberculosis treatment, prevention in 12 years and older

FDA approves generic baloxavir marboxil for flu treatment, prophylaxis

FDA clears Capvaxive as supplemental PCV for at-risk children

Immune endotype linked to poorer recovery in pediatric sepsis, organ failure

FDA expands TOFIDENCE (tocilizumab-bavi) indications to include CAR T-cell–induced CRS and pediatric COVID-19

Latest CME

Progress in Hyperlipidemia Management to Reduce ASCVD Risk: An Illustrated Update

Trending on Contemporary Pediatrics

AAP updates guidance on pediatric iron deficiency screening and treatment

Pediatric clinical trial update: Q2 2026

FDA expands roflumilast cream approval to children as young as 2 years with plaque psoriasis

FDA updates in pediatric care: Q2 2026 recap

5 FDA decisions to watch for during 2H 2026